✦ LIBER ✦

Quality indicators in a mycobacteriology laboratory supporting clinical trials for pulmonary tuberculosis

✍ Scribed by N. Selvakumar; K. Silambuchelvi; M. Gomathi Sekar; A. Syam Sunder; S. Anbarasu; V. Banu Rekha; C. Ponnuraja; Vanaja Kumar

Book ID: 118453863
Publisher: Medknow Publications
Year: 2012
Tongue: English
Weight: 165 KB
Volume: 1
Category: Article
ISSN: 2212-5531
DOI: 10.1016/j.ijmyco.2012.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pulmonary function in cannabis users: Su

Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer

✍ Nicholas T. Van Dam; Mitch Earleywine 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Routine use of the gen-probe MTD2 amplif

Routine use of the gen-probe MTD2 amplification test for detection of Mycobacterium tuberculosis in clinical specimens in a large public health mycobacteriology laboratory

✍ Pamela Chedore; Frances B Jamieson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Controlled clinical trial of three short

Controlled clinical trial of three short-course regimens of chemotherapy for pulmonary tuberculosis in Nigeria—A preliminary report

✍ B.O. Onadeko; A.A. Awotedu; B.O. Ogunbanjo; E.B. Aderinto 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Rifapentine and isoniazid once a week ve

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 108 KB

Rifapentine and isoniazid once a week ve

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 108 KB

## Background: Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis. we aimed to compare rifapentine and isoniazid once a week with rifampicin and isoniazid twice a week. ## Methods: We did a randomised, multicentre, open-label trial in the u